Outcomes summary

Randomized controlled study in healthy adults evaluating endocrine effects (GH and IGF-I secretion) after administration of CJC-1295, a long-acting GHRH analog.

Limitations

Early-phase study focused on hormonal biomarkers rather than clinical outcomes; generalizability to other populations is unknown.

Notes

Primary source: PMID 16352683 (see PubMed link on this page).